APGE Stock Analysis: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$84.24
0.07 (0.08%)
▲
5d:
+7.27%
30d:
+22.98%
90d:
+11.19%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Distribution
APGE is up 15.8% this week, but smart money is buying puts. Top strike: $65 2026-05-15 with 30 OI. Put ratio: 67% View Scanner →
Strength: 9.6/10
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: APGE is 11.9% above fair value ($75.31). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: APGE is 11.9% above fair value ($75.31). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $84.24, which is considered extended relative to its 30-day fair value range of $68.40 to $75.31.
Technical Outlook: Technically, APGE is in a uptrend. The price is approaching resistance at $85.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: APGE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $116.87 (+38.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APGE is in a uptrend. The price is approaching resistance at $85.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: APGE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $116.87 (+38.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$68.40 -
$75.31
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding APGE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.9% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 38.7% below Wall St target ($116.87)
Fair Price Analysis
30-Day Fair Range
$68.40 -
$75.31
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$65.22
Resistance Level
$85.94
Current Trend
Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.45
Wall Street Target
$116.87
(+38.7%)
Share & Embed Analysis
Last updated: April 02, 2026 4:18 AM ET
Data refreshes hourly during market hours. Next update: 5:18 AM
Data refreshes hourly during market hours. Next update: 5:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Thomas Henderson
SELL
20000 shares
2026-03-11
Carl Dambkowski
SELL
5500 shares
2026-03-04
Michael Thomas Henderson
SELL
20000 shares
2026-02-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 48 HOLD |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
